| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of Research &Technology
2 companies
Davis Gregory D serves as a Head Of Research &Technology at SGMOQ and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $49K at current prices.
The biggest single holding is SGMOQ (~$29K) as Head Of Research &Technology. The recent filings there lean toward selling, a net 69,827 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | SGMOQ Sangamo Therapeutics, Inc. | Head Of Research &Technology | Sell | 69,827 | $0.25 | $17,694.16 | -37.7% |